tandem stock price target

An Industry Subrating of High. A target price of 54000000.

Korea Capital Market Institute

NASDAQTNDM Get Rating has been given a consensus rating of Hold by the fifteen analysts that are currently covering the firm.

. A Safety Subrating of Low. This is based on 12 Wall Streets Analysts 12-month price targets issued in the past 3 months. TNDM was reported by Barclays on October 18 2022.

The forecasts range from a low of 4900 to a high of. TANDEM DIABETES CARE INC has an Investment Rating of HOLD. The analyst firm set a price target for 7500.

Tandem Diabetes Care Inc. Based on analysts offering 12 month price targets for TNDM in the last 3 months. According to 19 analysts the average rating for TNDM stock is Buy The 12-month stock price forecast is 8992 which is an increase of 6126 from the latest price.

Tandem Diabetes Care stock price target raised to 34 from 25 at Stifel Nicolaus. TANDEM DIABETES CARE INCs. TANDEM DIABETES CARE INC has an Investment Rating of HOLD.

The current price of Tandem Diabetes is the price at which Tandem Diabetes Care is currently. Find the latest Tandem Diabetes Care Inc TNDM stock price forecast 12-month price target predictions and analyst recommendations. Tandem Diabetes current and average target prices are 5436 and 13350 respectively.

TNDM have received a 200 price target from Lake Street. Cowen decreased their target price on Tandem Diabetes Care from 14100 to 10700 in a research. According to 8 Wall Street analyst s that have issued a 1 year TNDM price target the average TNDM price target is 8638 with the highest TNDM stock price forecast at 13000 and the.

A Management Subrating of Medium. ET by Tomi Kilgore. The latest price target for Tandem Diabetes Care NASDAQ.

Tandem 25000 000 000. The latest price target for Tandem Diabetes Care NASDAQ. TNDM was reported by Barclays on Tuesday October 18 2022.

A Management Subrating of Medium. These are the details. An Industry Subrating of High.

The shares of Tandem Diabetes Care Inc NASDAQ. Tandem Diabetes current and average target prices are 5389 and 13350 respectively. To contextualize these metrics consider that out of all US stocks TANDEM DIABETES CARE INCs average analyst price target is greater than 204205 of them.

Based on short-term price targets offered by 10 analysts the average price target for Tandem Diabetes Care Inc. The average price target is 000 with a high estimate of 000 and a low estimate of 000. Tandem Groups stock was trading at GBX 56110 on January 1st 2022.

Since then TND shares have decreased by 492 and is now trading at GBX 285. Stock Price Forecast The 14 analysts offering 12-month price forecasts for Tandem Diabetes Care Inc have a median target of 7800 with a high estimate of 15000 and a low estimate of. A target price of 54000000.

A Safety Subrating of Low. TNDM have received a 200 price target from Lake Street. 22 2018 at 835 am.

They issued an overweight rating and a 7500 target price on the stock. The highest analyst price target. The average price target for Tandem Diabetes Care is 8825.

The analyst firm set a price target for 7500 expecting TNDM to rise to. Stock news by MarketWatch. And Lake Street analyst Brooks ONeil.

Tandem Diabetes Care Inc Research Ratings Tndm Barron S